Neopterin and soluble CD14 (sCD14) levels as immunoactivation markers in aHBc-only cases

Pari Sohrabi, Zafer Habip, Suat Saribas, Asli Vatan, Harika Oyku Dinc, Yagiz M. Altun, Tevhide Ziver, Reyhan Caliskan, Mehmet Demirci, Omer Uysal, Pelin Yuksel, Bekir Kocazeybek

Research output: Contribution to journalArticlepeer-review

Abstract

Aim: Isolated hepatitis B core antibodies (aHBc)-only pattern complicates the diagnosis of HBV infections. We evaluated neopterin and sCD14 levels in HBV infections. Methods: aHBc-only (n: 102), healthy control (healthy control group [HCG], n: 100), and chronic hepatitis (CHB) groups (n: 70) were investigated. Competitive and sandwich ELISA were used. Results: The mean neopterin levels were significantly lower in the aHBc-only group than those in the CHB group (p = 0.0001). No significant difference was found between the aHBc-only group and the HCG (p = 0.854). The mean sCD14 levels were lower in the aHBc-only group than those in the CHB group (p = 0.0001), but no significant difference was found between the aHBc-only group and HCG (p = 0.402). No significant difference was detected between aHBc-only and HCG for mean sCD14 (p = 0.402) and neopterin levels (p = 0.854). Conclusion: These two biomarkers are not useful for diagnosing the aHBc only pattern.

Original languageEnglish (US)
Pages (from-to)409-419
Number of pages11
JournalFuture Virology
Volume12
Issue number8
DOIs
StatePublished - Aug 2017
Externally publishedYes

Keywords

  • HBV
  • isolated anti-HBc (aHBc-only)
  • neopterin
  • sCD14

ASJC Scopus subject areas

  • Virology

Fingerprint

Dive into the research topics of 'Neopterin and soluble CD14 (sCD14) levels as immunoactivation markers in aHBc-only cases'. Together they form a unique fingerprint.

Cite this